An integrated population pharmacokinetic model of febuxostat in pediatric patients with hyperuricemia including gout and adult population of healthy subjects and patients with renal dysfunction
Abstract The study objective was to validate febuxostat dosage and administration in pediatric patients with hyperuricemia including gout, using an integrated population pharmacokinetic (PopPK) analysis in the Japanese population. Integrated PopPK analysis of febuxostat used a nonlinear mixed‐effect...
Saved in:
| Main Authors: | Ryutaro Iwama, Kimie Nishida, Daisuke Ishii, Takeshi Iijima |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Pharmacology Research & Perspectives |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/prp2.70032 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Awareness of Gout and Hyperuricemia in a Sample of the Adult Population in Iraq
by: Shaimaa Jubair, et al.
Published: (2022-06-01) -
The efficacy of a low-dose combination of febuxostat and benzbromarone versus each drug used alone for the treatment of gout
by: Caiyu Zheng, et al.
Published: (2025-02-01) -
Problems of adherence to therapy in patients with gout in real clinical practice
by: Elena V. Shchemeleva, et al.
Published: (2024-11-01) -
External validation of population pharmacokinetic models of gentamicin in paediatric population from preterm newborns to adolescents
by: Črček Mateja, et al.
Published: (2023-06-01) -
Review and External Evaluation of Population Pharmacokinetic Models for Vedolizumab in Patients with Inflammatory Bowel Disease: Assessing Predictive Performance and Clinical Applicability
by: Marija Jovanović, et al.
Published: (2024-12-01)